OSTX
OS Therapies Incorporated
0.8722
-0.04 (-4.48%)
52w low 0.5800
2.25 high
17.5% of range
Financial Analysis
| (USD) | Dec 21 | Dec 22 | Dec 23 | Dec 24 | Dec 25 | Trend |
|---|---|---|---|---|---|---|
| Cash & Equivalents | -- | 171.48K | 38.98K | 5.53M | 269.83K | |
| Receivables | 231.07K | 1.15K | 0.00 | -- | -- | |
| Current Assets | -- | 496.83K | 790.03K | 5.53M | 332.91K | |
| Net PP&E | -- | 12.27K | 8.05K | 5.27K | 2.49K | |
| Total Assets | -- | 509.11K | 798.08K | 5.54M | 6.84M | |
| Current Liabilities | -- | 6.15M | 24.71M | 4.63M | 11.76M | |
| Total Debt | 7.07M | 10.35M | 14.61M | -- | -- | |
| Total Liabilities | -- | 18.07M | 24.81M | 8.81M | 12.94M | |
| Retained Earnings | -- | -21.60M | -29.52M | -38.43M | -67.19M | |
| Shareholders Equity | -- | -17.56M | -24.02M | -3.27M | -6.10M | |
| Working Capital | -- | -5.65M | -23.92M | 906.22K | -11.43M | |
| Shares Outstanding | -- | 20.60M | 20.60M | 20.87M | 37.11M |
Revenue CAGR
--
Net Income CAGR
--
EPS CAGR
--
FCF CAGR
--
Revenue YoY
--